Physician profile
Maria Markarian
NPI 1861490641
$22,206.97
in general payments reported to CMS, 2019-2025
36 companies · $2,195 in 2025
The $2,195 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,888 · 2020: $2,484 · 2021: $3,853 · 2022: $3,114 · 2023: $3,378 · 2024: $2,295 · 2025: $2,195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,868.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,867.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $2,788.64 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $2,285.35 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $2,248.71 | 2019-2025 | Farxiga, Brilinta, Wainua |
| Amgen INC. | $1,902.80 | 2019-2025 | Repatha, Repatha, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $1,614.18 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,217.26 | 2019-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,082.98 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $1,069.42 | 2019-2025 | Patientcare Link, Lux-Dx Insertable Cardiac Monitor |
| Merck Sharp & Dohme LLC | $1,033.75 | 2021-2025 | Verquvo |
| Abbott Laboratories | $1,003.05 | 2019-2024 | Jot Dx, Gallant |
| Amarin Pharma, INC. | $871.06 | 2019-2022 | |
| Pfizer INC. | $870.16 | 2019-2025 | |
| Esperion Therapeutics, INC. | $625.19 | 2020-2025 | Nexletol |
| Regeneron Healthcare Solutions, INC. | $521.58 | 2019-2025 | Evkeeza, Praluent |
| Novo Nordisk INC | $478.84 | 2022-2025 | Ozempic, Wegovy |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $475.44 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $322.94 | 2023-2024 | Inpefa |
| E.R. Squibb & Sons, L.L.C. | $306.63 | 2019-2022 | |
| Biotronik INC. | $177.68 | 2020-2022 | |
| Alnylam Pharmaceuticals INC. | $166.15 | 2021-2025 | Amvuttra |
| Baxter Healthcare | $153.22 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Medtronic Vascular, INC. | $144.18 | 2019 | |
| Gilead Sciences, INC. | $130.67 | 2019 | |
| Shockwave Medical, INC | $128.01 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $112.07 | 2019-2021 | |
| Abiomed | $76.46 | 2019-2020 | |
| Kiniksa Pharmaceuticals International, Plc | $68.00 | 2024 | Arcalyst |
| Lundbeck LLC | $65.52 | 2019-2020 | |
| Inspire Medical Systems, INC. | $63.62 | 2024-2025 | Inspire |
| Heartflow, INC. | $45.24 | 2024 | |
| Lilly USA, LLC | $36.91 | 2022-2023 | Mounjaro |
| Teleflex LLC | $36.74 | 2019 | |
| Philips North America LLC | $26.42 | 2024 | (Ck7) Extended Holter |
| Kiniksa Pharmaceuticals, LTD. | $21.40 | 2021 | |
| Irhythm Technologies, INC. | $19.84 | 2023 | Zio Xt Patch |
| Medicomp INC | $16.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Markarian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.